Gain Therapeutics GANX
NASDAQ GANX
$2.01 +0.03 (+1.26%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Shares Outstanding (Entity) (2020 - 2026)

Gain Therapeutics (GANX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Gain Therapeutics 85.97 Mn 85.97 Mn - 43.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 43.34 Mn
Mar 31, 2026 42.49 Mn
Dec 31, 2025 32.97 Mn
Sep 30, 2025 35.98 Mn
Jun 30, 2025 30.77 Mn
Mar 31, 2025 28.75 Mn
Dec 31, 2024 27.13 Mn
Sep 30, 2024 25.96 Mn
Jun 30, 2024 19.22 Mn
Mar 31, 2024 18.04 Mn
Dec 31, 2023 13.01 Mn
Sep 30, 2023 12.78 Mn
Jun 30, 2023 12.63 Mn
Mar 31, 2023 12.09 Mn
Dec 31, 2022 11.88 Mn
Sep 30, 2022 11.88 Mn
Jun 30, 2022 11.88 Mn
Mar 31, 2022 11.88 Mn
Dec 31, 2021 11.88 Mn
Sep 30, 2021 11.88 Mn